TAK-385 enters into phase 2 clinical trials in Japan
29 August 2011 | By Takeda Pharmaceutical Company Limited
TAK-385 used for the treatment of endometriosis and uterine fibroids...
List view / Grid view
29 August 2011 | By Takeda Pharmaceutical Company Limited
TAK-385 used for the treatment of endometriosis and uterine fibroids...
5 August 2011 | By Takeda Pharmaceutical Company Limited
Collaboration will explore potential of other assets to address obesity epidemic...
22 July 2011 | By Takeda Pharmaceutical Company Limited
The EMA has recommended changes to the label of pioglitazone-containing medicines...
19 July 2011 | By Takeda Pharmaceutical Company Limited
Millennium announced the submission of a supplemental New Drug Application (sNDA) with the U.S. FDA for VELCADE® (bortezomib)...
14 March 2011 | By Takeda Pharmaceutical Company Limited (Takeda)
Takeda have announced a 300 million Japanese yen donation to aid emergency relief for the earthquake on March 11...